FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
ANI Pharma (NASDAQ: ANIP) reported Q4 EPS of $0.84, may not compare to the analyst estimate of $1.09. Revenue for the quarter came in at $38.2 million versus the consensus estimate of $40.71 million.
GUIDANCE:
ANI Pharma sees FY2017 EPS of... More

